Prescription and over-the-counter medication recalls
Drug recalls come from the FDA's drug enforcement reports. They range from a wrong label to a product that could be harmful, and the risk level on each notice is the FDA's own classification. Never stop a prescribed medication on the strength of a recall notice alone — the notice will say whether to return it, and your prescriber or pharmacist decides what replaces it.
4,474 stored notices, reported between Jun 20, 2012 and Sep 9, 2026. Newest first.
Reported Sep 18, 2019
Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC:…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.American Health Packaging
FDA (openFDA drug enforcement)
Reported Sep 18, 2019
AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mg, 500 Tablets per bottle, NDC 42291-297-50.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.AVKARE Inc.
FDA (openFDA drug enforcement)
Reported Sep 18, 2019
20% Acetyl-L-Cysteine Ophthalmic Solutions, dispensed in 3ml dropper bottle.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Compounded Solutions in Pharmacy
2 more products in this recall
FDA (openFDA drug enforcement)
Reported Sep 18, 2019
Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc.…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Macleods Pharma USA Inc.
FDA (openFDA drug enforcement)
Reported Sep 18, 2019
Gatifloxacin Ophthalmic Solution 0.5%, 2.5 mL per bottle, Rx Only, Mfd. for: Mylan Pharmaceuticals Inc., Morgantown, WV…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Mylan Pharmaceuticals Inc.
FDA (openFDA drug enforcement)
Reported Sep 18, 2019
Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pacifico National, Inc. dba AmEx Pharmacy
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Sep 18, 2019
Bacteriostatic Water for Injection, USP, 30 mL vials, Rx only, Mfd. for: Hospira, Inc., Lake Forest, IL 60045 USA. NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pfizer Inc.
FDA (openFDA drug enforcement)
Reported Sep 18, 2019
Milk of Magnesia USP, 2400 mg/30 mL, Magnesium Hydroxide 2400 mg, 30 mL unit dose cups, For Institutional Use Only,…
High riskUsing this product could cause serious injury, illness or death — stop using it now.Plastikon Healthcare LLC
FDA (openFDA drug enforcement)
Reported Sep 4, 2019
Eptifibatide Injection, 75 mg/100 mL (0.75 mg/mL), 100 mL Single-use Vial, For Intravenous Use Only, Rx Only,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Akorn, Inc.
2 more products in this recall
FDA (openFDA drug enforcement)
Reported Sep 4, 2019
Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Alkermes Inc.
FDA (openFDA drug enforcement)
Reported Sep 4, 2019
Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC Dayton NJ 08810…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Aurobindo Pharma USA Inc.
FDA (openFDA drug enforcement)
Reported Sep 4, 2019
RELPAX (eletriptan HBr) tablets, 40 mg, packaged in a) 6-count (1 card x 6 tablets) per carton, NDC 0049-2340-45; b)…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pfizer Inc.
FDA (openFDA drug enforcement)
Reported Aug 28, 2019
Clear eyes REDNESS RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.012%) eye drops, packaged in a) 0.5 FL OZ (15…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Medtech Products, Inc.
13 more products in this recall
FDA (openFDA drug enforcement)
Reported Aug 28, 2019
Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection for IV or IM Use (concentration = 10 mg/mL), 6 mL Syringe, Rx…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.SCA Pharmaceuticals, LLC
FDA (openFDA drug enforcement)
Reported Aug 28, 2019
Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Upsher Smith Laboratories, Inc.
FDA (openFDA drug enforcement)
Reported Aug 21, 2019
Nitrofurantoin Monohydrate/Macrycrystals Capsules, 100 mg, 100-count bottle, Rx Only, Distributed by: Alvogen, Inc.…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Alvogen, Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Aug 21, 2019
Aspirin and Extended-release Dipyridamole Capsules, 25 mg/200 mg, 20 capsules per carton (5 blister cards x 4 unit…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.American Health Packaging
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Aug 21, 2019
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Glenmark Pharmaceuticals Inc., USA
FDA (openFDA drug enforcement)
Reported Aug 21, 2019
Oxytocin 60 units/1000 mL Lactated Ringers Intravenous Solution, Rx Only, Infusion Options, Inc. 5924 13the Ave,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Infusion Options, Inc.
75 more products in this recall
FDA (openFDA drug enforcement)
Reported Aug 21, 2019
Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg, 100 tablet bottle, Rx only, Manufactured by for: Lupin…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Lupin Pharmaceuticals Inc.
FDA (openFDA drug enforcement)
Reported Aug 21, 2019
Tamsulosin Hydrochloride Capsules, USP 0.4 mg Rx only a) 100 count (NDC 33342-159-11), b) 500 count (NDC 33342-159-15)…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Macleods Pharma USA Inc.
FDA (openFDA drug enforcement)
Reported Aug 21, 2019
CVS Health Glycerin Suppositories, 50-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895.…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.US Pharmaceuticals Inc.
17 more products in this recall
FDA (openFDA drug enforcement)
Reported Aug 14, 2019
Smart Sense Regular Strength Aspirin Tablets, 325 mg packed in a) 100 count UPC 8-8397-38781-6 and b) 500 count UPC…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.AAA Pharmaceutical, Inc.
FDA (openFDA drug enforcement)
Reported Aug 14, 2019
Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NDC…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.American Health Packaging
FDA (openFDA drug enforcement)
Free recall alerts
Get alerted about new Medication recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.
Related categories
RecallNow is not a government agency. Every notice above was published by the FDA, USDA FSIS or CPSC and links back to its source. Browse the whole archive.